뇌경색 급성기에서 N-말단 전구 나트륨이뇨 펩타이드의 유용성
Value of N-terminal pro-Brain Natriuretic Peptide in Acute Stage of Ischemic Stroke
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background: Brain natriuretic peptide (BNP) is expected to play a role in hemodynamic modulation. Its biologically inactive fragment, the 76-amino-acid N-terminal proBNP (NT-pro-BNP), was known as one of the biologic markers of congestive heart failure and other clinical situations. But, there are controversies about clinical significance of NT-pro-BNP in ischemic stroke. This study was performed to find the clinical significance of NT- pro-BNP in early stage of acute ischemic stroke. Methods: NT-pro-BNP levels were measured in 610 consecutive patients who admitted to the department of neurology at Chonnam National University Hospital. 205 patients were excluded due to incomplete follow-up period (more than 2 weeks), systemic infection, and etc. 286 ischemic stroke patients and 119 patients as control subjects were enrolled. NT-pro-BNP levels between stroke group and control were analyzed. When the patients in stroke group had more than 300 pg/mL of NT-pro-BNP, they were regarded as high group and the others were low group. National Institute of Health Stroke Scale (NIHSS) was checked at admission and 2 weeks later. Relationship between changes of NIHSS and the NT-pro-BNP level was also investigated. Results: The NT-pro-BNP levels were significantly increased in ischemic stroke patients (830.87 pg/mL) compared with control group (378.27 pg/mL) (p=0.002). And the high levels of NT-pro-BNP in stroke patients were related to severity on admission and cardioembolic infarction. But there was no correlation between NT-pro-BNP and improvement of NIHSS. Conclusions: In this study, significant relationship between the severity of ischemic stroke and NT-pro-BNP was found. But NT-pro-BNP was not related to early prognosis of ischemic stroke.KeyWords:Natriuretic peptide, Stroke, Prognosis
참고문헌 (31)
- "Incidence, risk, and case fatality of first ever stroke in the elderly population: the Rotterdam Study", 74, pp.317~321 (2003)
- "Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease", 135, pp.914~923 (1998)
- "Plasma natriuretic peptide levels and the risk of cardiovascular events and death", 350, pp.655~663 (2004)
- Yeo KT, "Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay", 338, pp.107~115 (2003)
- de Lemos JA, "B-type natriuretic peptide in cardiovascular disease", 362, pp.316~322 (2003)
- Gill D, "Vigorous response in plasma N-terminal pro- brain natriuretic peptide (NT-BNP) to acute myocardial infarction", 106, pp.135~139 (2004)
- Pruszczyk P, "N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism", 22, pp.649~653 (2003)
- Etgen T, "Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not related to clinical prognosis", 36, pp.270~275 (2005)
- Campbell DJ, "Soluble vascular cell adhesion molecule 1 and N-terminalpro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease", 63, pp.60~65 (2006)
- Adams HP, "Classification of subtype of acute ischemic stroke Definitions for use in a multicenter clinicaltrial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", pp.35~41
- Januzzi JL, "The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study", 95, pp.948~954 (2005)
- Karl J, "Development of a novel, N-terminal-proBNP (NT- proBNP) assay with a low detection limit", 230, pp.177~181 (1999)
- Rubattu S, "Atrial natriuretic peptide gene polymorphism and risk of ischemic stroke in humans", 35, pp.814~818 (2004)
- Estrada V, "High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke", 7, pp.1085~1089 (1994)
- Kazuhiko N, "Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke", 19, pp.157~164 (2005)
- Levin ER, "Natriuretic peptides", 339, pp.321~328 (1998)
- Bonow RO, "New insight into the cardiac natriuretic peptides", 93, pp.1946~1950 (1996)
- Myers MG, "Cardiac sequelae of acute stroke", 13, pp.838~842 (1982)
- Oppenheimer SM, "Neurology and the heart", 64, pp.289~297 (1998)
- Myers MG, "Plasma norepinephrine in stroke", 12, pp.200~204 (1981)
- Wallace JD, "Blood pressure after stroke", 246, pp.2177~2180 (1981)
- Campbell DJ, "Prediction of myocardial infarction by N- terminal pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease", 112, pp.110~116 (2005)
- Campbell DJ, "Prediction of heart failure by amine terminal- pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease", 45, pp.69~74 (2005)
- Makikallio AM, "Natriuretic peptides and mortality after stroke", 36, pp.1016~1020 (2005)
- George G, "N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke", 56, pp.723~730 (2005)
- Iltumur K, "Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke", 151, pp.1115~1122 (2006)
- Danesh J, "C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease", 350, pp.1387~1397 (2004)
- Tall AR, "C-reactive protein reassessed", 350, pp.1450~1452 (2004)
- Lee SH, "Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation", 70, pp.100~104 (2006)
- Lubien E, "Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings", 105, pp.595~601 (2002)
- Rodeheffer RJ, "Measuring plasma B-type natriuretic peptide in heart failure: Good to go in 2004?", 44, pp.740~749 (2004)